Lynda Charters

Treatment with a single ocriplasmin injection led to clinically meaningful improvements in the patient-reported visual function measured by the VFQ-25 questionnaire over 24 months in patients with symptomatic vitreomacular adhesion.

Only 2% of patients with internal limiting membrane peeling developed an epiretinal membrane compared with 46% with no peeling.

Fundus autofluorescence is a helpful tool for diagnosing central serous choroidopathy and planning treatment.

Immediate administration after radiation therapy is key.

This study provided clinical proof of concept for viral vector-mediated gene supplementation therapy of inherited day blindness caused by pathogenic variants in the cone photoreceptor-specific gene CNGA3.

Quiescence, steroid-free quiescence achieved in VISUAL III trial

Intravitreal triamcinolone acetonide, dexamethasone implant superior for regional treatment of disorder